Full versus half dose of antenatal betamethasone to prevent severe neonatal respiratory distress syndrome associated with preterm birth: study protocol for a randomised, multicenter, double blind, placebo-controlled, non-inferiority trial (betadose)

HIGHLIGHTS

• who: Thomas Schmitz from the Publique-Hôpitaux de Paris, boulevard Sérurier, Paris, France have published the Article: Full versus half dose of antenatal betamethasone to prevent severe neonatal respiratory distress syndrome associated with preterm birth: study protocol for a randomised, multicenter, double blind, placebo-controlled, non-inferiority trial (BETADOSE), in the Journal: (JOURNAL)
• what: The aim of this non-inferiority 1:1 randomised trial is to determine whether a 50% reduction of the antenatal betamethasone dose given to women at risk of very preterm delivery is not inferior to a full dose to . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.